This multicenter study assessed the antihypertensive safety and efficacy of L (PRINIVIL®) in children with hypertension age 6 to 16 yrs. The study was comprised of 115 pts; 41 from the U.S.,74 ex-U.S., 54 (47%) age 5-12 yrs, 61 (53%) age 13-16 yrs, 69 (60%) Tanner Stage ≤3, 75 (65.2%)were male, and 12 (10.4%) were Black.
